Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Reviews in Urology|February 4, 2016
Sipuleucel-T for the Treatment of Patients With Metastatic Castrate-resistant Prostate Cancer: Considerations for Clinical PracticeChristopher M Pieczonka, Dimitrios Telonis, Vladimir Mouraviev, et al.
Reviews in Urology|October 6, 2018
Effectiveness of Subcutaneously Administered Leuprolide Acetate to Achieve Low Nadir Testosterone in Prostate Cancer PatientsChristopher M Pieczonka, Przemyslaw Twardowski, Joseph Renzulli, et al.
BJUI Compass|March 19, 2025
Genomic prostate score and treatment selection in favourable intermediate-risk prostate cancerEric Margolis, Benjamin H Lowentritt, Christopher M Pieczonka, et al.
Reviews in Urology|October 23, 2014
The Rationale for Optimal Combination Therapy With Sipuleucel-T for Patients With Castration-resistant Prostate CancerVladimir Mouraviev, Neil Mariados, David Albala, et al.
Urology Practice|August 18, 2023
Hydrogel Spacer Application Technique, Patient Tolerance and Impact on Prostate Intensity Modulated Radiation Therapy: Results from a Prospective, Multicenter, Pivotal Randomized Controlled TrialChristopher M Pieczonka, Neil Mariados, John E Sylvester, et al.
Theranostics|May 7, 2026
Future opportunities and nuances with the use of PSMA PET in prostate cancer (MD PET 1)Alicia K Morgans, Christopher M Pieczonka, Evan Y W Yu, et al.
Urology|November 28, 2017
Absorbable Hydrogel Spacer Use in Prostate Radiotherapy: A Comprehensive Review of Phase 3 Clinical Trial Published DataLawrence I Karsh, Eric T Gross, Christopher M Pieczonka, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 14, 2023
Combination Treatment with Sipuleucel-T and Abiraterone Acetate or Enzalutamide for Metastatic Castration-Resistant Prostate Cancer: STAMP and STRIDE TrialsEmmanuel S Antonarakis, Sumit K Subudhi, Christopher M Pieczonka, et al.
NEJM Evidence|February 6, 2024
Enzalutamide and Quality of Life in Biochemically Recurrent Prostate CancerStephen J Freedland, Martin Gleave, Ugo De Giorgi, et al.
Urologic Oncology|April 20, 2020
Development and evaluation of the MiCheck test for aggressive prostate cancerNeal D Shore, Christopher M Pieczonka, R Jonathan Henderson, et al.
Pageof 3